CellaVision AB
↗Lund, Sweden
CellaVision is a world-leading provider of digital hematology microscopy solutions, including analyzers, instruments, reagents, and software. The company automates the workflow in hematology laboratories of all sizes, enabling the digital analysis of blood and body fluid samples to improve diagnostic accuracy and efficiency.
Founded in 1994 and headquartered in Lund, Sweden, CellaVision leverages artificial intelligence, deep learning, and digital imaging to standardize and simplify manual cell morphology analysis. The company serves hospitals and commercial laboratories globally, operating through a network of partners and market support offices in over 40 countries.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:
Industry:Medical Devices
Sub-Industry:Digital Hematology / Laboratory Automation
SIZE & FINANCIALS
Employees:201-500
Revenue:$70M-$80M
Founded:1994
Ownership:public
Status:operating
STOCK
Exchange:Nasdaq Stockholm
Ticker:CELLA
Market Cap:$0.39B
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Diagnostic Technology)
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Sysmex Corporation (Strategic alliance extended until 2038 for integrated hematology solutions)
COMPETITION
Position:Leader
Competitors:Livo, MicroX Labs, LabNow
LEADERSHIP
Key Executives:
Christer Fåhraeus - Founder
Scientific Founders:Christer Fåhraeus
LINKS
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of CellaVision AB and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with CellaVision AB. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.